Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK4 | Q16654 | 1/20 | 0.49 |
| ▸ | GRM5 | P41594 | 9/20 | 0.46 |
| ▸ | GRM1 | Q13255 | 9/20 | 0.46 |
| ▸ | NAMPT | P43490 | 1/20 | 0.43 |
| ▸ | HTR6 | P50406 | 1/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2002272 | 0.85 | PDK4 (0.48) | PDK4GRM5GRM1NAMPTHTR6 | |
| SCHEMBL12566963 | 0.85 | PDK4 (0.48) | PDK4GRM5GRM1NAMPTHTR6 | |
| SCHEMBL29120639 | 0.85 | PDK4 (0.40) | PDK4GRM5GRM1NAMPTESR2 | |
| SCHEMBL2349369 | 0.84 | PDK4 (0.47) | PDK4GRM5GRM1NAMPTHTR6 | |
| SCHEMBL12074148 | 0.84 | PDK4 (0.47) | PDK4GRM5GRM1NAMPTHTR6 | |
| SCHEMBL28161050 | 0.84 | PDK4 (0.47) | PDK4GRM5GRM1NAMPTHTR6 | |
| SCHEMBL2003552 | 0.84 | PDK4 (0.47) | PDK4GRM5GRM1NAMPTHTR6 | |
| SCHEMBL6662189 | 0.84 | PDK4 (0.47) | PDK4GRM5GRM1NAMPTHTR6 | |
| SCHEMBL5392226 | 0.84 | PDK4 (0.46) | PDK4GRM5GRM1NAMPTHTR6 | |
| SCHEMBL4532704 | 0.83 | PDK4 (0.46) | PDK4GRM5GRM1NAMPTHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7271174-B2 | Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases | SCHERING CORPORATION (US) | 2007-09-18 | — | — | US | disclosed |
| US-7271174-B2 | Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases | SCHERING CORPORATION (US) | 2007-09-18 | — | — | US | disclosed |
| US-6518423-B1 | These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and | EISAI CO., LTD. (JP) | 2003-02-11 | — | — | US | disclosed |
| EP-0934941-A1 | BENZOPIPERIDINE DERIVATIVES | Eisai Co., Ltd. (JP) | 1999-08-11 | — | — | EP | disclosed |